Health authorities in England have launched a vaccination campaign targeting young people at heightened risk of meningitis B infection. The initiative aims to protect approximately one million individuals, primarily consisting of 17 and 18-year-olds in secondary education and students under 25 entering residential university or college settings for the first time this autumn. The campaign was prompted by an outbreak in Kent, which resulted in 29 confirmed or suspected cases and two deaths.
The MenB vaccine requires two doses administered at least 28 days apart to provide complete protection. Nearly 90,000 doses have already been administered, with an additional 135,000 appointments scheduled for the coming weeks. Eligible individuals can access the vaccine through high street pharmacies across England, either by booking appointments through the NHS National Booking Service or via walk-in services. International students and those from other UK nations studying in England are also eligible for the vaccination program.
Meningitis B is a bacterial infection capable of causing serious complications including inflammation of the brain’s lining and blood poisoning, potentially resulting in death or permanent disabilities such as hearing loss or amputations. Research indicates that first-year university students face approximately seven times higher risk than similar-aged peers who do not attend university, attributed to increased social contact and shared living arrangements. The infection spreads through close contact such as kissing, sharing drinks, or living in proximity to infected individuals.
The vaccine became part of the routine childhood immunization program for babies born on or after July 1, 2015, but older teenagers and young adults have not previously received it through standard NHS programs. Health officials note that while the vaccine cannot cause meningitis and contains no live bacteria, common side effects may include injection site swelling and mild systemic symptoms that typically resolve within one to two days. Vaccine experts have recommended that government consider routinely offering MenB vaccination to all teenagers around age 15, pending ministerial decision-making in each UK nation.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI